A New Era in Treatment of Early-Stage Non-small Cell Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 234
Special Issue Editor
Interests: segmentectomy for NSCLC; perioperative systemic therapy for NSCLC; clinical trials of lung cancer surgery
Special Issue Information
Dear Colleagues,
The standard of care for early-stage non-small cell lung cancer (NSCLC) has changed dramatically with increasing evidence for minimally invasive surgery, such as video-assisted thoracic surgery (VATS) and robotic-assisted thoracic surgery (RATS); sublobar resection, such as segmentectomy or wedge resection; and perioperative immunotherapy or targeted therapy.
We are pleased to invite you to submit your experimental and theoretical results regarding new treatments for early-stage NSCLC. Full experimental details must be provided so that the results can be reproduced.
This Special Issue aims to encourage scientists to publish their own institutional experiences and scientific results regarding the new normal for the treatment of early-stage NSCLC, which includes minimally invasive surgery, sublobar resection, or perioperative therapy, and to understand and apply the development of this new era of early-stage NSCLC treatment in their daily clinical practice.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Minimally invasive surgery for lung cancer.
- Sublobar resection for early-stage NSCLC.
- Perioperative therapy for early-stage NSCLC.
I look forward to receiving your contributions.
Prof. Dr. Tsutani Yasuhiro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- minimally invasive surgery
- video-assisted thoracic surgery
- robotic-assisted thoracic surgery
- sublobar resection
- segmentectomy
- neoadjuvant therapy
- adjuvant therapy
- immunotherapy
- targeted therapy
